Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5080904 | 1.00 | GAA (0.55) | GAAALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL5081739 | 0.93 | GAA (0.62) | GAAALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL5569071 | 0.86 | GAA (0.69) | GAAALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL5081758 | 0.83 | GAA (0.46) | GAAALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL5078684 | 0.83 | GAA (0.46) | GAAALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL5080935 | 0.83 | GAA (0.46) | GAAALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL5567730 | 0.81 | GAA (0.78) | GAAALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL5081795 | 0.78 | GAA (0.52) | GAAALDH1A1SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL282760 | 0.78 | PKM (0.42) | GAAALDH1A1CYP2D6KDM4EMAPK1 | |
| SCHEMBL6140108 | 0.77 | GAA (0.67) | GAAALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1462471-B1 | Dielectric films and materials therefor | DAICEL CHEM (JP) | 2008-07-30 | — | — | EP | disclosed |
| US-20070078256-A1 | Prepolymers, prepolymer compositions, high-molecular-weight polymers with pore structure, and dielectric films | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-7186454-B2 | Dielectric films and materials therefor | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-20070032556-A1 | Aromatic polyamine derivative | DAICEL CHEMICAL INSUSTRIES, LTD. (JP) | 2007-02-08 | — | — | US | disclosed |
| US-20060264667-A1 | Adamantanetricarboxylic acid derivatives | NAGANO SHINYA | 2006-11-23 | — | — | US | disclosed |
| US-7102027-B2 | Adamantanetricarboxylic acid derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-09-05 | — | — | US | disclosed |
| EP-1683822-A1 | PREPOLYMER, PREPOLYMER COMPOSITION, HIGH MOLECULAR WEIGHT POLYMER HAVING STRUCTURE CONTAINING HOLE AND ELECTRICALLY INSULATING FILM | Daicel Chemical Industries, Ltd. (JP) | 2006-07-26 | — | — | EP | disclosed |
| EP-1681284-A1 | AROMATIC POLYAMINE DERIVATIVE | Daicel Chemical Industries, Ltd. (JP) | 2006-07-19 | — | — | EP | disclosed |
| EP-1505053-A1 | Adamantanetricarboxylic acid derivatives | Daicel Chemical Industries, Ltd. (JP) | 2005-02-09 | — | — | EP | disclosed |
| US-20040242923-A1 | Adamantanetricarboxylic acid derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1462471-A1 | Dielectric films and materials thereof | Daicel Chemical Industries, Ltd. (JP) | 2004-09-29 | — | — | EP | disclosed |
| US-20040175858-A1 | Dielectric films and materials therefor | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242923-A1 | Adamantanetricarboxylic acid derivatives | HCAR1, CA1, ALDH7A1 | GAA 1492/4885ALDH1A1 13/4885SLC6A2 2995/4885 |
| US-20070032556-A1 | Aromatic polyamine derivative | SRM, PRMT1, KDM8 | GAA 4582/4885ALDH1A1 179/4885SLC6A2 2059/4885 |
| US-20060264667-A1 | Adamantanetricarboxylic acid derivatives | CA1, HCAR1, ALDH7A1 | GAA 874/4885ALDH1A1 23/4885SLC6A2 2678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.